Koga Y - Search Results

1

Dynamics of the neutrophil‑to‑lymphocyte ratio during lenvatinib treatment for unresectable hepatocellular carcinoma.

Kuwano A, Yada M, Koga Y, Tanaka K, Ohishi Y, Masumoto A, Motomura K. Kuwano A, et al. Among authors: koga y. Oncol Lett. 2024 May 10;28(1):309. doi: 10.3892/ol.2024.14442. eCollection 2024 Jul. Oncol Lett. 2024. PMID: 38784605 Free PMC article.

2

An Imaging Feature Predicts Efficacy of Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma.

Kuwano A, Yada M, Miyazaki Y, Tanaka K, Koga Y, Ohishi Y, Masumoto A, Motomura K. Kuwano A, et al. Among authors: koga y. Cancer Diagn Progn. 2023 Jul 3;3(4):468-474. doi: 10.21873/cdp.10241. eCollection 2023 Jul-Aug. Cancer Diagn Progn. 2023. PMID: 37405218 Free PMC article.

3

FIB‑4 index and serum α‑fetoprotein are useful predictors of hepatocellular carcinoma occurrence in hepatitis B patients with nucleos(t)ide analogs therapy.

Kuwano A, Miyazaki M, Yada M, Tanaka K, Koga Y, Masumoto A, Motomura K. Kuwano A, et al. Among authors: koga y. Exp Ther Med. 2023 Aug 1;26(3):441. doi: 10.3892/etm.2023.12140. eCollection 2023 Sep. Exp Ther Med. 2023. PMID: 37614433 Free PMC article.

4

Potential Predictive Biomarkers of Systemic Drug Therapy for Hepatocellular Carcinoma: Anticipated Usefulness in Clinical Practice.

Motomura K, Kuwano A, Tanaka K, Koga Y, Masumoto A, Yada M. Motomura K, et al. Among authors: koga y. Cancers (Basel). 2023 Aug 30;15(17):4345. doi: 10.3390/cancers15174345. Cancers (Basel). 2023. PMID: 37686621 Free PMC article. Review.

5

Neutrophil-to-Lymphocyte Ratio Predicts Immune-related Adverse Events in Patients With Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab.

Kuwano A, Yada M, Tanaka K, Koga Y, Nagasawa S, Masumoto A, Motomura K. Kuwano A, et al. Among authors: koga y. Cancer Diagn Progn. 2024 Jan 3;4(1):34-41. doi: 10.21873/cdp.10282. eCollection 2024 Jan-Feb. Cancer Diagn Progn. 2024. PMID: 38173658 Free PMC article.

6

Systemic Chemotherapy for Advanced Hepatocellular Carcinoma in Patients With Child-Pugh class B.

Kuwano A, Yada M, Tanaka K, Koga Y, Nagasawa S, Masumoto A, Motomura K. Kuwano A, et al. Among authors: koga y. Cancer Diagn Progn. 2024 Mar 3;4(2):111-116. doi: 10.21873/cdp.10295. eCollection 2024 Mar-Apr. Cancer Diagn Progn. 2024. PMID: 38434920 Free PMC article.

7

Kuwano A, Yada M, Tanaka K, Koga Y, Nagasawa S, Masumoto A, Motomura K. Kuwano A, et al. Among authors: koga y. In Vivo. 2024 Jul-Aug;38(4):1854-1858. doi: 10.21873/invivo.13639. In Vivo. 2024. PMID: 38936922 Free PMC article.

8

Diagnostic features of autoimmune hepatitis in SARS‑CoV‑2‑vaccinated vs. unvaccinated individuals.

Kuwano A, Nagasawa S, Koga Y, Tanaka K, Yada M, Masumoto A, Motomura K. Kuwano A, et al. Among authors: koga y. Exp Ther Med. 2024 Jun 26;28(3):337. doi: 10.3892/etm.2024.12626. eCollection 2024 Sep. Exp Ther Med. 2024. PMID: 39006455 Free PMC article.

9

Posterior cardiac drain for atrial fibrillation after aortic valve replacement.

Koga Y, Sato M, Sadashima E, Ushigusa J, Kawasaki H, Kamohara K. Koga Y, et al. SAGE Open Med. 2024 Nov 16;12:20503121241296566. doi: 10.1177/20503121241296566. eCollection 2024. SAGE Open Med. 2024. PMID: 39552764 Free PMC article.

10

Commenting on "Early intramuscular adrenaline administration is associated with improved survival from out-of-hospital cardiac arrest".

Koga Y, Fujita M, Kaneda K, Tsuruta R. Koga Y, et al. Resuscitation. 2024 Nov;204:110401. doi: 10.1016/j.resuscitation.2024.110401. Resuscitation. 2024. PMID: 39547785 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,868 results

Search Page

Filters